AAAAAA
Results: 1-25/29
Authors:
MINSKY BD
COIA L
HALLER DG
HOFFMAN J
JOHN M
LANDRY J
PISANSKY TM
WILLETT C
MAHON I
OWEN J
BERKEY B
KATZ A
HANKS G
Citation: Bd. Minsky et al., RADIATION-THERAPY FOR RECTOSIGMOID AND RECTAL-CANCER - RESULTS OF THE1992-1994 PATTERNS OF CARE PROCESS SURVEY, Journal of clinical oncology, 16(7), 1998, pp. 2542-2547
Authors:
SMITH TJ
RYAN LM
DOUGLASS HO
HALLER DG
DAYAL Y
KIRKWOOD J
TORMEY DC
SCHUTT AJ
HINSON J
SISCHY B
Citation: Tj. Smith et al., COMBINED CHEMORADIOTHERAPY VS. RADIOTHERAPY ALONE FOR EARLY-STAGE SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP, International journal of radiation oncology, biology, physics, 42(2), 1998, pp. 269-276
Authors:
ROSENTHAL MA
GREEN M
WIERNIK P
BORDEN EC
MARSH JC
HALLER DG
Citation: Ma. Rosenthal et al., EPIRUBICIN HAS MODEST SINGLE-AGENT ACTIVITY IN HEAD AND NECK-CANCER BUT LIMITED ACTIVITY IN METASTATIC MELANOMA AND COLORECTAL-CANCER - PHASE-II STUDIES BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP, American journal of clinical oncology, 21(5), 1998, pp. 509-512
Authors:
GRAHAM RA
WANG S
CATALANO PJ
HALLER DG
Citation: Ra. Graham et al., POSTSURGICAL SURVEILLANCE OF COLON-CANCER - PRELIMINARY COST-ANALYSISOF PHYSICIAN EXAMINATION, CARCINOEMBRYONIC ANTIGEN TESTING, CHEST-X-RAY, AND COLONOSCOPY, Annals of surgery, 228(1), 1998, pp. 59-63
Authors:
GOLDBERG RM
FLEMING TR
TANGEN CM
MOERTEL CG
MACDONALD JS
HALLER DG
LAURIE JA
Citation: Rm. Goldberg et al., SURGERY FOR RECURRENT COLON-CANCER - STRATEGIES FOR IDENTIFYING RESECTABLE RECURRENCE AND SUCCESS RATES AFTER RESECTION, Annals of internal medicine, 129(1), 1998, pp. 27
Authors:
HALLER DG
SAROSY G
THURN A
HUBBARD SM
Citation: Dg. Haller et al., PDQ - A COMPREHENSIVE CANCER INFORMATION DATABASE - THE US EXPERIENCE, European journal of cancer, 33, 1997, pp. 1324-1324
Authors:
LICHTENSTEIN GR
HALLER DG
Citation: Gr. Lichtenstein et Dg. Haller, COLORECTAL-CARCINOMA - PREFACE, Hematology/oncology clinics of North America, 11(4), 1997, pp. 11-12
Authors:
VAUGHN DJ
HALLER DG
Citation: Dj. Vaughn et Dg. Haller, THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF COLORECTAL-CANCER, Hematology/oncology clinics of North America, 11(4), 1997, pp. 699
Authors:
VAUGHN DJ
HALLER DG
Citation: Dj. Vaughn et Dg. Haller, ADJUVANT THERAPY FOR COLORECTAL-CANCER - PAST ACCOMPLISHMENTS, FUTURE-DIRECTIONS, Cancer investigation, 15(5), 1997, pp. 435-447
Authors:
OCONNELL MJ
MAILLIARD JA
KAHN MJ
MACDONALD JS
HALLER DG
MAYER RJ
WIEAND HS
Citation: Mj. Oconnell et al., CONTROLLED TRIAL OF FLUOROURACIL AND LOW-DOSE LEUCOVORIN GIVEN FOR 6 MONTHS AS POSTOPERATIVE ADJUVANT THERAPY FOR COLON-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 246-250
Authors:
VAUGHN DJ
MEROPOL NJ
HOLROYDE C
MINTZER D
NUAMAH I
ARMSTEAD B
DOUGLASS HO
HALLER DG
Citation: Dj. Vaughn et al., A PHASE-II STUDY OF 5-FLUOROURACIL, LEUCOVORIN, ADRIAMYCIN, AND CISPLATIN (FLAP) FOR METASTATIC GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA - A PENN CANCER CLINICAL-TRIAL GROUP AND ROSWELL PARK CANCERINSTITUTE COMMUNITY ONCOLOGY RESEARCH-PROGRAM TRIAL, American journal of clinical oncology, 20(3), 1997, pp. 242-246
Authors:
HALLER DG
Citation: Dg. Haller, TRIMETREXATE - EXPERIENCE WITH SOLID TUMORS, Seminars in oncology, 24(5), 1997, pp. 71-76
Authors:
HANSEN RM
RYAN L
ANDERSON T
KRZYWDA B
QUEBBEMAN E
BENSON A
HALLER DG
TORMEY DC
Citation: Rm. Hansen et al., PHASE-III STUDY OF BOLUS VERSUS INFUSION FLUOROURACIL WITH OR WITHOUTCISPLATIN IN ADVANCED COLORECTAL-CANCER, Journal of the National Cancer Institute, 88(10), 1996, pp. 668-674
Authors:
ROTHENBERG ML
MOORE MJ
CRIPPS MC
ANDERSEN JS
PORTENOY RK
BURRIS HA
GREEN MR
TARASSOFF PG
BROWN TD
CASPER ES
STORNIOLO AM
VONHOFF DD
ALBERTS DS
WOLFF R
KELSEN DP
KOCHA W
HALLER DG
MODIANOREVAH M
MOORE M
OKEN MM
SCHILSKY RL
SHAH A
Citation: Ml. Rothenberg et al., A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER, Annals of oncology, 7(4), 1996, pp. 347-353
Authors:
VAUGHN DJ
MEROPOL NJ
ARMSTEAD B
HALLER DG
Citation: Dj. Vaughn et al., A PILOT TRIAL OF 5-FU, LEUCOVORIN, AND CISPLATIN WITH OR WITHOUT ADRIAMYCIN IN ADVANCED CANCER, American journal of clinical oncology, 19(3), 1996, pp. 241-244
Authors:
HALLER DG
Citation: Dg. Haller, AN OVERVIEW OF ADJUVANT THERAPY FOR COLORECTAL-CANCER, European journal of cancer, 31A(7-8), 1995, pp. 1255-1263
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
TANGEN CM
UNGERLEIDER JS
EMERSON WA
TORMEY DC
GLICK JH
VEEDER MH
MAILLIARD JA
Citation: Cg. Moertel et al., INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2936-2943
Authors:
WHITTINGTON R
NEUBERG D
TESTER WJ
BENSON AB
HALLER DG
Citation: R. Whittington et al., PROTRACTED INTRAVENOUS FLUOROURACIL INFUSION WITH RADIATION-THERAPY IN THE MANAGEMENT OF LOCALIZED PANCREATICOBILIARY CARCINOMA - A PHASE-IEASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL, Journal of clinical oncology, 13(1), 1995, pp. 227-232
Authors:
CLARK JL
KUCUK O
NEUBERG DS
BENSON AB
TAYLOR SG
PANDYA KJ
MANSOUR EG
DOUGLASS HO
HALLER DG
Citation: Jl. Clark et al., PHASE-II TRIAL OF ETOPOSIDE, DOXORUBICIN, AND CISPLATIN COMBINATION IN ADVANCED MEASURABLE GASTRIC-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(4), 1995, pp. 318-324
Authors:
VAUGHN DJ
HALLER DG
Citation: Dj. Vaughn et Dg. Haller, RECENT ADVANCES IN COLORECTAL-CANCER - INTRODUCTION, Seminars in oncology, 22(5), 1995, pp. 415-417
Authors:
COHEN AM
KANE MJ
ENGSTROM PF
MARKS JH
MARKS GJ
HALLER DG
SCHNEIDER CJ
LAUCIUS JF
MASTRANGELO MJ
Citation: Am. Cohen et al., DUKES C2 COLON-CANCER - WHAT IS APPROPRIATE FOLLOW-UP, Seminars in oncology, 22(3), 1995, pp. 19
Authors:
MARTENSON JA
LIPSITZ SR
LEFKOPOULOU M
ENGSTROM PF
DAYAL YY
COBAU CD
OKEN MM
HALLER DG
Citation: Ja. Martenson et al., RESULTS OF COMBINED-MODALITY THERAPY FOR PATIENTS WITH ANAL CANCER (E7283) - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP-STUDY, Cancer, 76(10), 1995, pp. 1731-1736
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
TANGEN CM
UNGERLEIDER JS
EMERSON WA
TORMEY DC
GLICK JH
VEEDER MH
MAILLIARD JA
GRAFF J
Citation: Cg. Moertel et al., FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT, Annals of internal medicine, 122(5), 1995, pp. 321-326
Authors:
ASBURY RF
CNAAN A
JOHNSON L
HARRIS J
ZAENTZ SD
HALLER DG
Citation: Rf. Asbury et al., AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-II STUDY OF SINGLE-AGENT DHAD, VP-16, ACLACINOMYCIN, OR SPIROGERMANIUM IN METASTATIC PANCREATIC-CANCER, American journal of clinical oncology, 17(2), 1994, pp. 166-169
Authors:
OCONNELL M
MARTENSON JA
WIEAND HS
KROOK JE
MACDONALD JS
HALLER DG
MAYER RJ
GUNDERSON LL
RICH TA
Citation: M. Oconnell et al., IMPROVING ADJUVANT THERAPY FOR RECTAL-CANCER BY COMBINING PROTRACTED-INFUSION FLUOROURACIL WITH RADIATION-THERAPY AFTER CURATIVE SURGERY, The New England journal of medicine, 331(8), 1994, pp. 502-507